Epigenetic mechanisms in anti-cancer actions of bioactive food components - The implications in cancer prevention

British Journal of Pharmacology

Volumn 167, Issue 2, 2012, Pages 279-297

  Stefanska, B ^a,b   Karlic, H ^c   Varga, F ^c   Fabianowska Majewska, K ^a   Haslberger, A G ^d  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b MCGILL UNIVERSITY   (Canada)

^c HANUSCH HOSPITAL   (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

anti cancer action; chemoprevention; epigenetics; natural compounds

Indexed keywords

BETAINE; CARBON; CHOLINE; COBALAMIN; COLECALCIFEROL; CURCUMIN; DAIDZEIN; DNA; DNA METHYLTRANSFERASE; EPIGALLOCATECHIN GALLATE; FOLIC ACID; GENISTEIN; HISTONE; HISTONE ACETYLTRANSFERASE; METHIONINE; MICRORNA; PARTHENOLIDE; PIPERINE; PYRIDOXINE; RESVERATROL; RETINOIC ACID; RIBOFLAVIN; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; SELENIUM; SIRTUIN; UNTRANSLATED RNA; VITAMIN D;

ANTINEOPLASTIC ACTIVITY; CANCER PREVENTION; CARBON METABOLISM; CARCINOGENESIS; DIET SUPPLEMENTATION; DNA METHYLATION; DNA MODIFICATION; DNA SEQUENCE; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; ENZYME INHIBITION; EPIGENETICS; FOOD COMPOSITION; GENE EXPRESSION; GENE MUTATION; GENETIC STABILITY; HISTONE MODIFICATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUTRIENT CONTENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SOCIAL ASPECT; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; EPIGENESIS, GENETIC; FOOD ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS;

EID: 84865436447     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02002.x     Document Type: Review

References (247)

1. Alhosin M, Sharif T, Mousli M, Etienne-Selloum N, Fuhrmann G, Schini-Kerth VB, et al,. (2011). Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J Exp Clin Cancer Res 30: 41.
2. Amin AR, Kucuk O, Khuri FR, Shin DM, (2009). Perspectives for cancer prevention with natural compounds. J Clin Oncol 27: 2712-2725.
3. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB, (2007). Bioavailability of curcumin: problems and promises. Mol Pharm 4: 807-818.
4. Arai N, Strom A, Rafter JJ, Gustafsson JA, (2000). Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem Biophys Res Commun 270: 425-431. (Pubitemid 30446852)
5. Arany I, Whitehead WE, Ember IA, Tyring SK, (2003). Dose-dependent activation of p21WAF1 transcription by all-trans-acid in cervical squamous carcinoma cells. Anticancer Res 23: 495-497. (Pubitemid 36358559)
6. Arima Y, Hirota T, Bronner C, Mousli M, Fujiwara T, Niwa S, et al,. (2004). Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes Cells 9: 131-142. (Pubitemid 38312957)
7. Asada K, Kotake Y, Asada R, Saunders D, Broyles RH, Towner RA, et al,. (2006). LINE-1 hypomethylation in a choline-deficiency-induced liver cancer in rats: dependence on feeding period. J Biomed Biotechnol 2006: 17142.
8. Attoub S, Hassan AH, Vanhoecke B, Iratni R, Takahashi T, Gaben AM, et al,. (2011). Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur J Pharmacol 651: 18-25.
9. Bai Y, Mao QQ, Qin J, Zheng XY, Wang YB, Yang K, et al,. (2010). Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci 101: 488-493.
10. Bannister AJ, Kouzarides T, (2011). Regulation of chromatin by histone modifications. Cell Res 21: 381-395.
11. Barnes S, Sfakianos J, Coward L, Kirk M, (1996). Soy isoflavonoids and cancer prevention. Underlying biochemical and pharmacological issues. Adv Exp Med Biol 401: 87-100. (Pubitemid 26326193)
12. Barreto G, Schafer A, Marhold J, Stach D, Swaminathan SK, Handa V, et al,. (2007). Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445: 671-675. (Pubitemid 46232889)
13. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al,. (2007). High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837. (Pubitemid 46802390)
14. Batta K, Zhang Z, Yen K, Goffman DB, Pugh BF, (2011). Genome-wide function of H2B ubiquitylation in promoter and genic regions. Genes Dev 25: 2254-2265.
15. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG, (2001). Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 10: 687-692. (Pubitemid 32331576)
16. Bemis DL, Katz AE, Buttyan R, (2006). Clinical trials of natural products as chemopreventive agents for prostate cancer. Expert Opin Investig Drugs 15: 1191-1200. (Pubitemid 44608259)
17. Benkoussa M, Brand C, Delmotte MH, Formstecher P, Lefebvre P, (2002). Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter. Mol Cell Biol 22: 4522-4534. (Pubitemid 34620390)
18. Bergmann A, Lane ME, (2003). HIDden targets of microRNAs for growth control. Trends Biochem Sci 28: 461-463. (Pubitemid 38340406)
19. Berner C, Aumuller E, Gnauck A, Nestelberger M, Just A, Haslberger AG, (2010). Epigenetic control of estrogen receptor expression and tumor suppressor genes is modulated by bioactive food compounds. Ann Nutr Metab 57: 183-189.
20. Bhattacharya SK, Ramchandani S, Cervoni N, Szyf M, (1999). A mammalian protein with specific demethylase activity for mCpG DNA. Nature 397: 579-583.
21. Bielecki A, Roberts J, Mehta R, Raju J, (2011). Estrogen receptor-beta mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones. Nutr Cancer 63: 139-150.
22. Bigey P, Ramchandani S, Theberge J, Araujo FD, Szyf M, (2000). Transcriptional regulation of the human DNA methyltransferase (dnmt1) gene. Gene 242: 407-418. (Pubitemid 30064527)
23. Bistulfi G, Vandette E, Matsui S, Smiraglia DJ, (2010). Mild folate deficiency induces genetic and epigenetic instability and phenotype changes in prostate cancer cells. BMC Biol 8: 6.
24. de Boer VC, de Goffau MC, Arts IC, Hollman PC, Keijer J, (2006). SIRT1 stimulation by polyphenols is affected by their stability and metabolism. Mech Ageing Dev 127: 618-627. (Pubitemid 43729534)
25. Borra MT, Smith BC, Denu JM, (2005). Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 280: 17187-17195. (Pubitemid 41389185)
26. Bostick M, Kim JK, Esteve PO, Clark A, Pradhan S, Jacobsen SE, (2007). UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 317: 1760-1764. (Pubitemid 47461842)
27. Bourc'his D, Bestor TH, (2004). Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 431: 96-99. (Pubitemid 39215115)
28. Bourc'his D, Xu GL, Lin CS, Bollman B, Bestor TH, (2001). Dnmt3L and the establishment of maternal genomic imprints. Science 294: 2536-2539. (Pubitemid 34027291)
29. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM, (2000). Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 141: 3657-3667.
30. Bronner C, Achour M, Arima Y, Chataigneau T, Saya H, Schini-Kerth VB, (2007). The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol Ther 115: 419-434. (Pubitemid 47362377)
31. Butterworth CE, Jr, Hatch KD, Gore H, Mueller H, Krumdieck CL, (1982). Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am J Clin Nutr 35: 73-82. (Pubitemid 12126589)
32. Cabanes A, Wang M, Olivo S, DeAssis S, Gustafsson JA, Khan G, et al,. (2004). Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 25: 741-748. (Pubitemid 38618526)
33. Calvisi DF, Simile MM, Ladu S, Pellegrino R, De Murtas V, Pinna F, et al,. (2007). Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis. Int J Cancer 121: 2410-2420. (Pubitemid 350022410)
34. Cedar H, Bergman Y, (2009). Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 10: 295-304.
35. Cervoni N, Szyf M, (2001). Demethylase activity is directed by histone acetylation. J Biol Chem 276: 40778-40787.
36. Chagas CE, Bassoli BK, de Souza CA, Deminice R, Junior AA, Paiva SA, et al,. (2011). Folic acid supplementation during early hepatocarcinogenesis: cellular and molecular effects. Int J Cancer doi: 10.1002/ijc.25886 [Epub ahead of print].
37. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, et al,. (1996). Role of CBP/P300 in nuclear receptor signalling. Nature 383: 99-103. (Pubitemid 26296470)
38. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, et al,. (1997). Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90: 569-580. (Pubitemid 27347246)
39. Chen T, Hevi S, Gay F, Tsujimoto N, He T, Zhang B, et al,. (2007a). Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells. Nat Genet 39: 391-396. (Pubitemid 46328497)
40. Chen Y, Shu W, Chen W, Wu Q, Liu H, Cui G, (2007b). Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells. Basic Clin Pharmacol Toxicol 101: 427-433. (Pubitemid 350135350)
41. Chik F, Szyf M, Rabbani SA, (2011). Role of epigenetics in cancer initiation and progression. Adv Exp Med Biol 720: 91-104.
42. Choi EJ, Kim GH, (2008). Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells. Phytomedicine 15: 683-690.
43. Choudhuri S, (2011). From Waddington's epigenetic landscape to small noncoding RNA: some important milestones in the history of epigenetics research. Toxicol Mech Methods 21: 252-274.
44. Chuang LS, Ian HI, Koh TW, Ng HH, Xu G, Li BF, (1997). Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science 277: 1996-2000. (Pubitemid 27449142)
45. Chung JH, Ostrowski MC, Romigh T, Minaguchi T, Waite KA, Eng C, (2006). The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation. Hum Mol Genet 15: 2553-2559. (Pubitemid 44288685)
46. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I, (2010). Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 501: 79-90.
47. Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, et al,. (2010). Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 170: 1622-1631.
48. Comb M, Goodman HM, (1990). CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res 18: 3975-3982.
49. Cornwell T, Cohick W, Raskin I, (2004). Dietary phytoestrogens and health. Phytochemistry 65: 995-1016. (Pubitemid 38542736)
50. Cui Y, Lu C, Liu L, Sun D, Yao N, Tan S, et al,. (2008). Reactivation of methylation-silenced tumor suppressor gene p16INK4a by nordihydroguaiaretic acid and its implication in G1 cell cycle arrest. Life Sci 82: 247-255.
51. Dace A, Martin-el Yazidi C, Bonne J, Planells R, Torresani J, (1997). Calcitriol is a positive effector of adipose differentiation in the OB 17 cell line: relationship with the adipogenic action of triiodothyronine. Biochem Biophys Res Commun 232: 771-776. (Pubitemid 27214074)
52. D'Alessio AC, Szyf M, (2006). Epigenetic tete-a-tete: the bilateral relationship between chromatin modifications and DNA methylation. Biochem Cell Biol 84: 463-476. (Pubitemid 44703651)
53. Das PM, Singal R, (2004). DNA methylation and cancer. J Clin Oncol 22: 4632-4642. (Pubitemid 41185132)
54. Das S, Foley N, Bryan K, Watters KM, Bray I, Murphy DM, et al,. (2010). MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiation. Cancer Res 70: 7874-7881.
55. Dashwood RH, Ho E, (2007). Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol 17: 363-369. (Pubitemid 47369168)
56. Daskalos A, Oleksiewicz U, Filia A, Nikolaidis G, Xinarianos G, Gosney JR, et al,. (2011). UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer. Cancer 117: 1027-1037.
57. Dave B, Eason RR, Till SR, Geng Y, Velarde MC, Badger TM, et al,. (2005). The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. Carcinogenesis 26: 1793-1803. (Pubitemid 41487996)
58. Davie JR, (2003). Inhibition of histone deacetylase activity by butyrate. J Nutr 133: 2485S-2493S. (Pubitemid 36828858)
59. Davis CD, Ross SA, (2008). Evidence for dietary regulation of microRNA expression in cancer cells. Nutr Rev 66: 477-482.
60. Davis CD, Uthus EO, (2004). DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) 229: 988-995. (Pubitemid 39431078)
61. Degos L, Dombret H, Chomienne C, Daniel MT, Miclea JM, Chastang C, et al,. (1995). All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 85: 2643-2653.
62. Detich N, Theberge J, Szyf M, (2002). Promoter-specific activation and demethylation by MBD2/demethylase. J Biol Chem 277: 35791-35794.
63. Dixon RA, Ferreira D, (2002). Genistein. Phytochemistry 60: 205-211. (Pubitemid 34947527)
64. Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL, (2006). Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 114: 567-572.
65. Druesne-Pecollo N, Latino-Martel P, (2011). Modulation of histone acetylation by garlic sulfur compounds. Anticancer Agents Med Chem 11: 254-259.
66. Duthie SJ, (2011). Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis 34: 101-109.
67. Duthie SJ, Narayanan S, Sharp L, Little J, Basten G, Powers H, (2004). Folate, DNA stability and colo-rectal neoplasia. Proc Nutr Soc 63: 571-578. (Pubitemid 40558053)
68. Ebbing M, Bonaa KH, Nygard O, Arnesen E, Ueland PM, Nordrehaug JE, et al,. (2009). Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 302: 2119-2126.
69. Eden S, Hashimshony T, Keshet I, Cedar H, Thorne AW, (1998). DNA methylation models histone acetylation. Nature 394: 842. (Pubitemid 28410897)
70. Fahrner JA, Eguchi S, Herman JG, Baylin SB, (2002). Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res 62: 7213-7218. (Pubitemid 36025241)
71. Fang M, Chen D, Yang CS, (2007). Dietary polyphenols may affect DNA methylation. J Nutr 137: 223S-228S. (Pubitemid 46052885)
72. Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS, (2005). Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 11: 7033-7041. (Pubitemid 41428763)
73. Feng J, Zhou Y, Campbell SL, Le T, Li E, Sweatt JD, et al,. (2010). Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 13: 423-430.
74. Fini L, Selgrad M, Fogliano V, Graziani G, Romano M, Hotchkiss E, et al,. (2007). Annurca apple polyphenols have potent demethylating activity and can reactivate silenced tumor suppressor genes in colorectal cancer cells. J Nutr 137: 2622-2628. (Pubitemid 350255288)
75. Fini L, Piazzi G, Daoud Y, Selgrad M, Maegawa S, Garcia M, et al,. (2011). Chemoprevention of intestinal polyps in ApcMin/+ mice fed with western or balanced diets by drinking annurca apple polyphenol extract. Cancer Prev Res (Phila) 4: 907-915.
76. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC, (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811. (Pubitemid 28099681)
77. Fujii T, Yokoyama G, Takahashi H, Namoto R, Nakagawa S, Toh U, et al,. (2008). Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancer. Breast Cancer 15: 73-78.
78. Fullgrabe J, Kavanagh E, Joseph B, (2011). Histone onco-modifications. Oncogene 30: 3391-3403.
79. Garcia-Pineres AJ, Lindenmeyer MT, Merfort I, (2004). Role of cysteine residues of p65/NF-kappaB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential. Life Sci 75: 841-856. (Pubitemid 38737421)
80. Ghoshal K, Li X, Datta J, Bai S, Pogribny I, Pogribny M, et al,. (2006). A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats. J Nutr 136: 1522-1527. (Pubitemid 43765356)
81. Gibbons RJ, McDowell TL, Raman S, O'Rourke DM, Garrick D, Ayyub H, et al,. (2000). Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat Genet 24: 368-371. (Pubitemid 30187434)
82. Gruenbaum Y, Naveh-Many T, Cedar H, Razin A, (1981). Sequence specificity of methylation in higher plant DNA. Nature 292: 860-862. (Pubitemid 11015506)
83. Guo JM, Xiao BX, Dai DJ, Liu Q, Ma HH, (2004). Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells in vitro. World J Gastroenterol 10: 860-863. (Pubitemid 38418362)
84. Gurlek A, Pittelkow MR, Kumar R, (2002). Modulation of growth factor/cytokine synthesis and signaling by 1alpha,25-dihydroxyvitamin D(3): implications in cell growth and differentiation. Endocr Rev 23: 763-786. (Pubitemid 35454588)
85. Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Peckitt C, Bliss J, et al,. (2004). Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res 10: 5472-5481. (Pubitemid 39100485)
86. Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS, et al,. (2005). The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 105: 4163-4169. (Pubitemid 40720758)
87. Hamm S, Just G, Lacoste N, Moitessier N, Szyf M, Mamer O, (2008). On the mechanism of demethylation of 5-methylcytosine in DNA. Bioorg Med Chem Lett 18: 1046-1049. (Pubitemid 351179349)
88. Haslberger A, Varga F, Karlic H, (2006). Recursive causality in evolution: a model for epigenetic mechanisms in cancer development. Med Hypotheses 67: 1448-1454. (Pubitemid 44468296)
89. Hatziapostolou M, Iliopoulos D, (2011). Epigenetic aberrations during oncogenesis. Cell Mol Life Sci 68: 1681-1702.
90. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, et al,. (2008). Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A 105: 17046-17049.
91. Hermann A, Gowher H, Jeltsch A, (2004). Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 61: 2571-2587. (Pubitemid 39586518)
92. Hisatake J, O'Kelly J, Uskokovic MR, Tomoyasu S, Koeffler HP, (2001). Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. Blood 97: 2427-2433. (Pubitemid 32291490)
93. Hotchkiss RD, (1948). The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography. J Biol Chem 175: 315-332.
94. Hsieh TC, Huang YC, Wu JM, (2011). Control of prostate cell growth, DNA damage and repair and gene expression by resveratrol analogues, in vitro. Carcinogenesis 32: 93-101.
95. Iida T, Suetake I, Tajima S, Morioka H, Ohta S, Obuse C, et al,. (2002). PCNA clamp facilitates action of DNA cytosine methyltransferase 1 on hemimethylated DNA. Genes Cells 7: 997-1007.
96. Inamdar NM, Ehrlich KC, Ehrlich M, (1991). CpG methylation inhibits binding of several sequence-specific DNA-binding proteins from pea, wheat, soybean and cauliflower. Plant Mol Biol 17: 111-123.
97. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, et al,. (1997). Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89: 166-170. (Pubitemid 27034793)
98. Iorio MV, Piovan C, Croce CM, (2010). Interplay between microRNAs and the epigenetic machinery: an intricate network. Biochim Biophys Acta 1799: 694-701.
99. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y, (2010). Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466: 1129-1133.
100. James SJ, Pogribny IP, Pogribna M, Miller BJ, Jernigan S, Melnyk S, (2003). Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. J Nutr 133: 3740S-3747S. (Pubitemid 37406630)
101. Jenuwein T, Allis CD, (2001). Translating the histone code. Science 293: 1074-1080. (Pubitemid 32758077)
102. Jha AK, Nikbakht M, Parashar G, Shrivastava A, Capalash N, Kaur J, (2010). Reversal of hypermethylation and reactivation of the RARbeta2 gene by natural compounds in cervical cancer cell lines. Folia Biol (Praha) 56: 195-200.
103. Johnson JJ, Nihal M, Siddiqui IA, Scarlett CO, Bailey HH, Mukhtar H, et al,. (2011). Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res 55: 1169-1176.
104. Kanduc D, Ghoshal A, Quagliariello E, Farber E, (1988). DNA hypomethylation in ethionine-induced rat preneoplastic hepatocyte nodules. Biochem Biophys Res Commun 150: 739-744. (Pubitemid 18039284)
105. Kang J, Chen J, Shi Y, Jia J, Zhang Y, (2005). Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. Biochem Pharmacol 69: 1205-1213. (Pubitemid 40417492)
106. Kanwal R, Gupta S, (2010). Epigenetics and cancer. J Appl Physiol 109: 598-605.
107. Kanwal R, Gupta S, (2011). Epigenetic modifications in cancer. Clin Genet 81: 303-311.
108. Karlic H, Varga F, (2011). Impact of vitamin D metabolism on clinical epigenetics. Clin Epigenet 2: 55-61.
109. Karlic H, Thaler R, Varga J, Berger C, Spitzer S, Pfeilstöcker M, et al,. (2010a). Effects of epigenetic drugs (vorinostat, decitabine) on metabolism-related pathway factors in leukemic cells. Open Leuk J 3: 34-42.
110. Karlic R, Chung HR, Lasserre J, Vlahovicek K, Vingron M, (2010b). Histone modification levels are predictive for gene expression. Proc Natl Acad Sci U S A 107: 2926-2931.
111. Khanim FL, Gommersall LM, Wood VH, Smith KL, Montalvo L, O'Neill LP, et al,. (2004). Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Oncogene 23: 6712-6725. (Pubitemid 39280003)
112. Khor TO, Huang Y, Wu TY, Shu L, Lee J, Kong AN, (2011). Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation. Biochem Pharmacol 82: 1073-1078.
113. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, et al,. (2008). Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer 123: 552-560. (Pubitemid 351898412)
114. Kim YI, (2004). Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 13: 511-519.
115. Koch CM, Andrews RM, Flicek P, Dillon SC, Karaoz U, Clelland GK, et al,. (2007). The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res 17: 691-707. (Pubitemid 46919707)
116. Kouzarides T, (2007). Chromatin modifications and their function. Cell 128: 693-705. (Pubitemid 46273577)
117. Kraunz KS, Nelson HH, Lemos M, Godleski JJ, Wiencke JK, Kelsey KT, (2006). Homozygous deletion of p16INK4a and tobacco carcinogen exposure in nonsmall cell lung cancer. Int J Cancer 118: 1364-1369.
118. Kriaucionis S, Heintz N, (2009). The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324: 929-930.
119. Kuzumaki T, Kobayashi T, Ishikawa K, (1998). Genistein induces p21(Cip1/WAF1) expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells. Biochem Biophys Res Commun 251: 291-295. (Pubitemid 28498105)
120. Lamond AI, Earnshaw WC, (1998). Structure and function in the nucleus. Science 280: 547-553. (Pubitemid 28227750)
121. Le Corre L, Fustier P, Chalabi N, Bignon YJ, Bernard-Gallon D, (2004). Effects of resveratrol on the expression of a panel of genes interacting with the BRCA1 oncosuppressor in human breast cell lines. Clin Chim Acta 344: 115-121. (Pubitemid 38626145)
122. Lee WJ, Zhu BT, (2006). Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 27: 269-277. (Pubitemid 43159879)
123. Lee WJ, Shim JY, Zhu BT, (2005). Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol 68: 1018-1030. (Pubitemid 41345793)
124. Levenson JM, Roth TL, Lubin FD, Miller CA, Huang IC, Desai P, et al,. (2006). Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J Biol Chem 281: 15763-15773. (Pubitemid 43848466)
125. Li B, Carey M, Workman JL, (2007). The role of chromatin during transcription. Cell 128: 707-719. (Pubitemid 46273570)
126. Li Y, Upadhyay S, Bhuiyan M, Sarkar FH, (1999). Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 18: 3166-3172. (Pubitemid 29261238)
127. Lin R, Nagai Y, Sladek R, Bastien Y, Ho J, Petrecca K, et al,. (2002). Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol 16: 1243-1256. (Pubitemid 34621073)
128. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al,. (2009). Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462: 315-322.
129. Liu HL, Chen Y, Cui GH, Zhou JF, (2005). Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation. Acta Pharmacol Sin 26: 603-609. (Pubitemid 40676173)
130. Liu M, Iavarone A, Freedman LP, (1996). Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 271: 31723-31728. (Pubitemid 26408639)
131. Liu YL, Yang HP, Gong L, Tang CL, Wang HJ, (2011). Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung cancer cell lines. Mol Med Report 4: 675-679.
132. Liu Z, Liu S, Xie Z, Pavlovicz RE, Wu J, Chen P, et al,. (2009a). Modulation of DNA methylation by a sesquiterpene lactone parthenolide. J Pharmacol Exp Ther 329: 505-514.
133. Liu Z, Xie Z, Jones W, Pavlovicz RE, Liu S, Yu J, et al,. (2009b). Curcumin is a potent DNA hypomethylation agent. Bioorg Med Chem Lett 19: 706-709.
134. Lopes N, Carvalho J, Duraes C, Sousa B, Gomes M, Costa JL, et al,. (2012). 1Alpha,25-dihydroxyvitamin D3 Induces de novo E-cadherin Expression in Triple-negative Breast Cancer Cells by CDH1-promoter Demethylation. Anticancer Res 32: 249-257.
135. Lovat F, Valeri N, Croce CM, (2011). MicroRNAs in the pathogenesis of cancer. Semin Oncol 38: 724-733.
136. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al,. (2005). MicroRNA expression profiles classify human cancers. Nature 435: 834-838. (Pubitemid 40839735)
137. Lu Q, Qiu X, Hu N, Wen H, Su Y, Richardson BC, (2006). Epigenetics, disease, and therapeutic interventions. Ageing Res Rev 5: 449-467. (Pubitemid 44437040)
138. Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V, et al,. (2009). BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 30: 662-670.
139. Mandal S, Davie JR, (2010). Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells. J Cell Physiol 224: 28-32.
140. Maradeo ME, Cairns P, (2011). Translational application of epigenetic alterations: ovarian cancer as a model. FEBS Lett 585: 2112-2120.
141. Marik R, Fackler M, Gabrielson E, Zeiger MA, Sukumar S, Stearns V, et al,. (2010). DNA methylation-related vitamin D receptor insensitivity in breast cancer. Cancer Biol Ther 10: 44-53.
142. Maruti SS, Ulrich CM, White E, (2009). Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr 89: 624-633.
143. Mastronardi FG, Noor A, Wood DD, Paton T, Moscarello MA, (2007). Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated. J Neurosci Res 85: 2006-2016. (Pubitemid 47051489)
144. Matsumura K, Tanaka T, Kawashima H, Nakatani T, (2008). Involvement of the estrogen receptor beta in genistein-induced expression of p21(waf1/cip1) in PC-3 prostate cancer cells. Anticancer Res 28: 709-714. (Pubitemid 351578912)
145. Miller CA, Sweatt JD, (2007). Covalent modification of DNA regulates memory formation. Neuron 53: 857-869. (Pubitemid 46367557)
146. Milutinovic S, Knox JD, Szyf M, (2000). DNA methyltransferase inhibition induces the transcription of the tumor suppressor p21(WAF1/CIP1/sdi1). J Biol Chem 275: 6353-6359. (Pubitemid 30129929)
147. Mittal A, Piyathilake C, Hara Y, Katiyar SK, (2003). Exceptionally high protection of photocarcinogenesis by topical application of (-)- epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia 5: 555-565. (Pubitemid 38045092)
148. Myzak MC, Dashwood RH, (2006). Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr Drug Targets 7: 443-452. (Pubitemid 43744834)
149. Nan X, Campoy FJ, Bird A, (1997). MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88: 471-481. (Pubitemid 27154412)
150. Narayanan BA, Narayanan NK, Re GG, Nixon DW, (2003). Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int J Cancer 104: 204-212. (Pubitemid 36249796)
151. Ndlovu MN, Denis H, Fuks F, (2011). Exposing the DNA methylome iceberg. Trends Biochem Sci 36: 381-387.
152. Newberne PM, Rogers AE, (1986). Labile methyl groups and the promotion of cancer. Annu Rev Nutr 6: 407-432.
153. Nian H, Delage B, Ho E, Dashwood RH, (2009). Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds. Environ Mol Mutagen 50: 213-221.
154. Okano M, Xie S, Li E, (1998). Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 19: 219-220. (Pubitemid 28309328)
155. Okano M, Bell DW, Haber DA, Li E, (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257. (Pubitemid 29519904)
156. Olthof MR, Hollman PC, Zock PL, Katan MB, (2001). Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. Am J Clin Nutr 73: 532-538. (Pubitemid 32176503)
157. Palmer HG, Sanchez-Carbayo M, Ordonez-Moran P, Larriba MJ, Cordon-Cardo C, Munoz A, (2003). Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res 63: 7799-7806. (Pubitemid 37466712)
158. Paluszczak J, Baer-Dubowska W, (2005). Epigenome and cancer: new possibilities of cancer prevention and therapy? Postepy Biochem 51: 244-250.
159. Paluszczak J, Krajka-Kuzniak V, Baer-Dubowska W, (2010). The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol Lett 192: 119-125.
160. Pan L, Matloob AF, Du J, Pan H, Dong Z, Zhao J, et al,. (2010). Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A/sodium butyrate-induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation. FEBS J 277: 989-999.
161. Papoutsis AJ, Borg JL, Selmin OI, Romagnolo DF, (2011). BRCA-1 promoter hypermethylation and silencing induced by the aromatic hydrocarbon receptor-ligand TCDD are prevented by resveratrol in MCF-7 Cells. J Nutr Biochem doi: 10.1016/j.jnutbio.2011.08.001 [Epub ahead of print].
162. Parasramka MA, Ho E, Williams DE, Dashwood RH, (2012). MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals. Mol Carcinog 51: 213-230.
163. Peng H, Xiong H, Li J, Xie M, Liu Y, Bai C, et al,. (2010). Vanilin cross-linked chitosan microspheres for controlled release of resveratrol. Food Chem 121: 23-28.
164. Pethe V, Shekhar PV, (1999). Estrogen inducibility of c-Ha-ras transcription in breast cancer cells. Identification of functional estrogen-responsive transcriptional regulatory elements in exon 1/intron 1 of the c-Ha-ras gene. J Biol Chem 274: 30969-30978.
165. Popp C, Dean W, Feng S, Cokus SJ, Andrews S, Pellegrini M, et al,. (2010). Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463: 1101-1105.
166. Pozo-Guisado E, Alvarez-Barrientos A, Mulero-Navarro S, Santiago-Josefat B, Fernandez-Salguero PM, (2002). The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem Pharmacol 64: 1375-1386. (Pubitemid 35248254)
167. Pozo-Guisado E, Lorenzo-Benayas MJ, Fernandez-Salguero PM, (2004). Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer 109: 167-173. (Pubitemid 38240916)
168. Pratt MA, Deonarine D, Teixeira C, Novosad D, Tate BF, Grippo JF, (1996). The AF-2 region of the retinoic acid receptor alpha mediates retinoic acid inhibition of estrogen receptor function in breast cancer cells. J Biol Chem 271: 20346-20352. (Pubitemid 26281801)
169. Privat M, Aubel C, Arnould S, Communal Y, Ferrara M, Bignon YJ, (2010). AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines. Anticancer Res 30: 2049-2054.
170. Qin W, Zhu W, Shi H, Hewett JE, Ruhlen RL, MacDonald RS, et al,. (2009). Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women. Nutr Cancer 61: 238-244.
171. Rahal OM, Simmen RC, (2010). PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation. Carcinogenesis 31: 1491-1500.
172. Rai K, Huggins IJ, James SR, Karpf AR, Jones DA, Cairns BR, (2008). DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell 135: 1201-1212.
173. Rajewsky N, (2006). microRNA target predictions in animals. Nat Genet 38 (Suppl.): S8-S13.
174. Ramchandani S, Bhattacharya SK, Cervoni N, Szyf M, (1999). DNA methylation is a reversible biological signal. Proc Natl Acad Sci U S A 96: 6107-6112. (Pubitemid 29256627)
175. Rauch TA, Wu X, Zhong X, Riggs AD, Pfeifer GP, (2009). A human B cell methylome at 100-base pair resolution. Proc Natl Acad Sci U S A 106: 671-678.
176. Razin A, Riggs AD, (1980). DNA methylation and gene function. Science 210: 604-610.
177. Razin A, Szyf M, Kafri T, Roll M, Giloh H, Scarpa S, et al,. (1986). Replacement of 5-methylcytosine by cytosine: a possible mechanism for transient DNA demethylation during differentiation. Proc Natl Acad Sci U S A 83: 2827-2831. (Pubitemid 16041756)
178. Reik W, Dean W, (2001). DNA methylation and mammalian epigenetics. Electrophoresis 22: 2838-2843. (Pubitemid 32851180)
179. Reuter S, Gupta SC, Park B, Goel A, Aggarwal BB, (2011). Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr 6: 93-108.
180. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, et al,. (1999). The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 27: 2291-2298. (Pubitemid 29245646)
181. Rosenfeld JA, Wang Z, Schones DE, Zhao K, DeSalle R, Zhang MQ, (2009). Determination of enriched histone modifications in non-genic portions of the human genome. BMC Genomics 10: 143.
182. Rowling MJ, McMullen MH, Schalinske KL, (2002). Vitamin A and its derivatives induce hepatic glycine N-methyltransferase and hypomethylation of DNA in rats. J Nutr 132: 365-369. (Pubitemid 34208734)
183. Saini S, Majid S, Dahiya R, (2010). Diet, microRNAs and prostate cancer. Pharm Res 27: 1014-1026.
184. Sanchez-Martinez R, Zambrano A, Castillo AI, Aranda A, (2008). Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers. Mol Cell Biol 28: 3817-3829. (Pubitemid 351732915)
185. Saramaki A, Diermeier S, Kellner R, Laitinen H, Vaisanen S, Carlberg C, (2009). Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1alpha,25- dihydroxyvitamin D3. J Biol Chem 284: 8073-8082.
186. Scott JM, Weir DG, (1998). Folic acid, homocysteine and one-carbon metabolism: a review of the essential biochemistry. J Cardiovasc Risk 5: 223-227. (Pubitemid 29030107)
187. Selhub J, (2002). Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J Nutr Health Aging 6: 39-42. (Pubitemid 35364170)
188. Selker EU, (1998). Trichostatin A causes selective loss of DNA methylation in Neurospora. Proc Natl Acad Sci U S A 95: 9430-9435. (Pubitemid 28506248)
189. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN, (2009). Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37: 223-230.
190. Sharif J, Muto M, Takebayashi S, Suetake I, Iwamatsu A, Endo TA, et al,. (2007). The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450: 908-912. (Pubitemid 350231331)
191. Sharif T, Auger C, Alhosin M, Ebel C, Achour M, Etienne-Selloum N, et al,. (2010). Red wine polyphenols cause growth inhibition and apoptosis in acute lymphoblastic leukaemia cells by inducing a redox-sensitive up-regulation of p73 and down-regulation of UHRF1. Eur J Cancer 46: 983-994.
192. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS, (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64: 353-356. (Pubitemid 28234275)
193. Shrubsole MJ, Shu XO, Li HL, Cai H, Yang G, Gao YT, et al,. (2011). Dietary B vitamin and methionine intakes and breast cancer risk among Chinese women. Am J Epidemiol 173: 1171-1182.
194. Shu L, Khor TO, Lee JH, Boyanapalli SS, Huang Y, Wu TY, et al,. (2011). Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. AAPS J 13: 606-614.
195. Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, Bispham J, et al,. (2007). DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci U S A 104: 19351-19356.
196. Singh SM, Murphy B, O'Reilly RL, (2003). Involvement of gene-diet/drug interaction in DNA methylation and its contribution to complex diseases: from cancer to schizophrenia. Clin Genet 64: 451-460. (Pubitemid 37493115)
197. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M, (1999). Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 8: 513-518. (Pubitemid 29270335)
198. Starlard-Davenport A, Tryndyak V, Kosyk O, Ross SR, Rusyn I, Beland FA, et al,. (2010). Dietary methyl deficiency, microRNA expression and susceptibility to liver carcinogenesis. World Rev Nutr Diet 101: 123-130.
199. Stefanska B, Rudnicka K, Bednarek A, Fabianowska-Majewska K, (2010). Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells. Eur J Pharmacol 638: 47-53.
200. Stefanska B, Huang J, Bhattacharyya B, Suderman M, Hallett M, Han ZG, et al,. (2011a). Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Res 71: 5891-5903.
201. Stefanska B, Salame P, Bednarek A, Fabianowska-Majewska K, (2011b). Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. Br J Nutr 107: 781-790.
202. Steger DJ, Lefterova MI, Ying L, Stonestrom AJ, Schupp M, Zhuo D, et al,. (2008). DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol 28: 2825-2839. (Pubitemid 351542379)
203. Stein R, Razin A, Cedar H, (1982). In vitro methylation of the hamster adenine phosphoribosyltransferase gene inhibits its expression in mouse L cells. Proc Natl Acad Sci U S A 79: 3418-3422. (Pubitemid 12011375)
204. Strahl BD, Allis CD, (2000). The language of covalent histone modifications. Nature 403: 41-45. (Pubitemid 30038513)
205. Su Y, Simmen FA, Xiao R, Simmen RC, (2007). Expression profiling of rat mammary epithelial cells reveals candidate signaling pathways in dietary protection from mammary tumors. Physiol Genomics 30: 8-16. (Pubitemid 47173284)
206. Swami S, Krishnan AV, Feldman D, (2000). 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clin Cancer Res 6: 3371-3379. (Pubitemid 30637769)
207. vel Szic KS, Ndlovu MN, Haegeman G, Vanden Berghe W, (2010). Nature or nurture: let food be your epigenetic medicine in chronic inflammatory disorders. Biochem Pharmacol 80: 1816-1832.
208. Szyf M, (2005). DNA methylation and demethylation as targets for anticancer therapy. Biochemistry (Mosc) 70: 533-549. (Pubitemid 40920798)
209. Szyf M, (2012). The early life social environment and DNA methylation. Clin Genet 81: 341-349.
210. Szyf M, Pakneshan P, Rabbani SA, (2004). DNA methylation and breast cancer. Biochem Pharmacol 68: 1187-1197. (Pubitemid 39094284)
211. Tan S, Wang C, Lu C, Zhao B, Cui Y, Shi X, et al,. (2009). Quercetin is able to demethylate the p16INK4a gene promoter. Chemotherapy 55: 6-10.
212. Tessitore L, Davit A, Sarotto I, Caderni G, (2000). Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21: 1619-1622. (Pubitemid 30608219)
213. Thaler R, Karlic H, Rust P, Haslberger AG, (2009). Epigenetic regulation of human buccal mucosa mitochondrial superoxide dismutase gene expression by diet. Br J Nutr 101: 743-749.
214. Tili E, Michaille JJ, Alder H, Volinia S, Delmas D, Latruffe N, et al,. (2010). Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFbeta signaling pathway in SW480 cells. Biochem Pharmacol 80: 2057-2065.
215. Tuddenham L, Wheeler G, Ntounia-Fousara S, Waters J, Hajihosseini MK, Clark I, et al,. (2006). The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett 580: 4214-4217. (Pubitemid 44037596)
216. Unoki M, Nishidate T, Nakamura Y, (2004). ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene 23: 7601-7610. (Pubitemid 39424918)
217. Unoki M, Brunet J, Mousli M, (2009). Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis. Biochem Pharmacol 78: 1279-1288.
218. Unterberger A, Szyf M, Nathanielsz PW, Cox LA, (2009). Organ and gestational age effects of maternal nutrient restriction on global methylation in fetal baboons. J Med Primatol 38: 219-227.
219. Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, Reinberg D, (2004). Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell 16: 93-105. (Pubitemid 39330155)
220. Vardi A, Bosviel R, Rabiau N, Adjakly M, Satih S, Dechelotte P, et al,. (2010). Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. In Vivo 24: 393-400.
221. Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, et al,. (2006). The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439: 871-874. (Pubitemid 43255707)
222. Voegel JJ, Heine MJ, Zechel C, Chambon P, Gronemeyer H, (1996). TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15: 3667-3675. (Pubitemid 26239779)
223. Waite KA, Sinden MR, Eng C, (2005). Phytoestrogen exposure elevates PTEN levels. Hum Mol Genet 14: 1457-1463. (Pubitemid 40823455)
224. Walle T, Hsieh F, DeLegge MH, Oatis JE, Jr, Walle UK, (2004). High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32: 1377-1382. (Pubitemid 39564557)
225. Wang LS, Arnold M, Huang YW, Sardo C, Seguin C, Martin E, et al,. (2011). Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase I pilot study. Clin Cancer Res 17: 598-610.
226. Wang Q, Lee D, Sysounthone V, Chandraratna RAS, Christakos S, Korah R, et al,. (2001). 1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects. Breast Cancer Res Treat 67: 157-168. (Pubitemid 32744496)
227. Watanabe T, Tomizawa S, Mitsuya K, Totoki Y, Yamamoto Y, Kuramochi-Miyagawa S, et al,. (2011). Role for piRNAs and noncoding RNA in de novo DNA methylation of the imprinted mouse Rasgrf1 locus. Science 332: 848-852.
228. Waterland RA, (2006). Assessing the effects of high methionine intake on DNA methylation. J Nutr 136: 1706S-1710S. (Pubitemid 43765384)
229. Waterland RA, Jirtle RL, (2003). Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23: 5293-5300. (Pubitemid 36950884)
230. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, et al,. (2004). Epigenetic programming by maternal behavior. Nat Neurosci 7: 847-854. (Pubitemid 38989508)
231. Wei EK, Giovannucci E, Selhub J, Fuchs CS, Hankinson SE, Ma J, (2005). Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women. J Natl Cancer Inst 97: 684-692. (Pubitemid 40812632)
232. Whitehead N, Reyner F, Lindenbaum J, (1989). The Journal of the American Medical Association, Volume 226, 1973: megaloblastic changes in cervical epithelium. Association with oral contraceptive therapy and reversal with folic acid. Nutr Rev 47: 318-321.
233. Whitsett TG, Jr, Lamartiniere CA, (2006). Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat. Expert Rev Anticancer Ther 6: 1699-1706. (Pubitemid 46062304)
234. Widschwendter M, Jones PA, (2002). DNA methylation and breast carcinogenesis. Oncogene 21: 5462-5482. (Pubitemid 34983482)
235. Wiedhopf RM, Young M, Bianchi E, Cole JR, (1973). Tumor inhibitory agent from Magnolia grandiflora (Magnoliaceae). I. Parthenolide. J Pharm Sci 62: 345.
236. Woynarowski JM, Konopa J, (1981). Inhibition of DNA biosynthesis in HeLa cells by cytotoxic and antitumor sesquiterpene lactones. Mol Pharmacol 19: 97-102. (Pubitemid 11104877)
237. Wu Q, Zhang M, Liu S, Chen Y, Su W, (2002). Retinoic acid receptor beta is required for anti-activator protein-1 activity by retinoic acid in gastric cancer cells. Chin Med J (Engl) 115: 810-814. (Pubitemid 34716387)
238. Wyatt GR, (1950). Occurrence of 5-methylcytosine in nucleic acids. Nature 166: 237-238.
239. Yang CS, Fang M, Lambert JD, Yan P, Huang TH, (2008). Reversal of hypermethylation and reactivation of genes by dietary polyphenolic compounds. Nutr Rev 66 (Suppl. 1): S18-S20.
240. Yang XJ, Seto E, (2007). HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26: 5310-5318. (Pubitemid 47255917)
241. Youssef EM, Lotan D, Issa JP, Wakasa K, Fan YH, Mao L, et al,. (2004). Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. Clin Cancer Res 10: 1733-1742. (Pubitemid 38435565)
242. Yu Z, Li W, Lu Q, Wang L, Zhang X, Han P, et al,. (2008). p21 is required for atRA-mediated growth inhibition of MEPM cells, which involves RAR. J Cell Biochem 104: 2185-2192.
243. Zapisek WF, Cronin GM, Lyn-Cook BD, Poirier LA, (1992). The onset of oncogene hypomethylation in the livers of rats fed methyl-deficient, amino acid-defined diets. Carcinogenesis 13: 1869-1872.
244. Zhang D, Holmes WF, Wu S, Soprano DR, Soprano KJ, (2000). Retinoids and ovarian cancer. J Cell Physiol 185: 1-20.
245. Zhang T, Kraus WL, (2010). SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions. Biochim Biophys Acta 1804: 1666-1675.
246. Zhou H, Hu H, Lai M, (2010). Non-coding RNAs and their epigenetic regulatory mechanisms. Biol Cell 102: 645-655.
247. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK, (1999). Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 129: 1628-1635. (Pubitemid 29406613)